Viridian Therapeutics, Inc.\DE (VRDN) Other Non-Current Assets (2013 - 2026)

Viridian Therapeutics, Inc.\DE's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $888000.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 81.6% year-over-year to $888000.0 in Q1 2026; TTM through Mar 2026 was $888000.0, a 81.6% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 206.59% from the prior year.
• Other Non-Current Assets retreated to $888000.0 in Q1 2026 per VRDN's latest filing, from $1.5 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $1.5 million in Q1 2022 and bottomed at $489000.0 in Q1 2025.
• The 5-year median for Other Non-Current Assets is $982000.0 (2022), against an average of $983764.7.
• Across the five-year window, Other Non-Current Assets surged 154100.0% in 2022 and tumbled 44.34% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $982000.0 in 2022, then sank by 38.49% to $604000.0 in 2023, then decreased by 17.05% to $501000.0 in 2024, then soared by 206.59% to $1.5 million in 2025, then slumped by 42.19% to $888000.0 in 2026.
• Per Business Quant, the three latest VRDN Other Non-Current Assets figures stand at $888000.0 (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025).